Schroder Investment Management Group I Teos Therapeutics, Inc. Transaction History

Schroder Investment Management Group

  • $94.5 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
SELL
$18.6 - $27.25 $767,845 - $1.12 Million
-41,282 Reduced 38.26%
66,609 $1.27 Million
Q2 2022

Aug 11, 2022
SELL
$16.57 - $35.1 $842,833 - $1.79 Million
-50,865 Reduced 32.04%
107,891 $2.17 Million
Q1 2022

May 16, 2022
BUY
$31.92 - $47.45 $5.07 Million - $7.53 Million
158,756 New
158,756 $5.08 Million

Others Institutions Holding ITOS

# of Institutions
169
Shares Held
36.6M
Call Options Held
1.95M
Put Options Held
374K
View Full List

About iTeos Therapeutics, Inc.

ITOS Quotes by TradingView
  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $285M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email